The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands

McDonald SA, van Lier A, Plaß D, Kretzschmar MEE (2012)
Bmc Public Health 12(1).

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ;
Abstract
Background: For accurate estimation of the future burden of communicable diseases, the dynamics of the population at risk - namely population growth and population ageing - need to be taken into account. Accurate burden estimates are necessary for informing policy-makers regarding the planning of vaccination and other control, intervention, and prevention measures. Our aim was to qualitatively explore the impact of population ageing on the estimated future burden of seasonal influenza and hepatitis B virus (HBV) infection in the Netherlands, in the period 2000-2030. Methods: Population-level disease burden was quantified using the disability-adjusted life years (DALY) measure applied to all health outcomes following acute infection. We used national notification data, pre-defined disease progression models, and a simple model of demographic dynamics to investigate the impact of population ageing on the burden of seasonal influenza and HBV. Scenario analyses were conducted to explore the potential impact of intervention-associated changes in incidence rates. Results: Including population dynamics resulted in increasing burden over the study period for influenza, whereas a relatively stable future burden was predicted for HBV. For influenza, the increase in DALYs was localised within YLL for the oldest age-groups (55 and older), and for HBV the effect of longer life expectancy in the future was offset by a reduction in incidence in the age-groups most at risk of infection. For both infections, the predicted disease burden was greater than if a static demography was assumed: 1.0 (in 2000) to 2.3-fold (in 2030) higher DALYs for influenza; 1.3 (in 2000) to 1.5-fold (in 2030) higher for HBV. Conclusions: There are clear, but diverging effects of an ageing population on the estimated disease burden of influenza and HBV in the Netherlands. Replacing static assumptions with a dynamic demographic approach appears essential for deriving realistic burden estimates for informing health policy.
Publishing Year
ISSN
PUB-ID

Cite this

McDonald SA, van Lier A, Plaß D, Kretzschmar MEE. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health. 2012;12(1).
McDonald, S. A., van Lier, A., Plaß, D., & Kretzschmar, M. E. E. (2012). The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health, 12(1).
McDonald, S. A., van Lier, A., Plaß, D., and Kretzschmar, M. E. E. (2012). The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health 12.
McDonald, S.A., et al., 2012. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health, 12(1).
S.A. McDonald, et al., “The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands”, Bmc Public Health, vol. 12, 2012.
McDonald, S.A., van Lier, A., Plaß, D., Kretzschmar, M.E.E.: The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health. 12, (2012).
McDonald, Scott A., van Lier, Alies, Plaß, Dietrich, and Kretzschmar, Mirjam E. E. “The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands”. Bmc Public Health 12.1 (2012).
This data publication is cited in the following publications:
This publication cites the following data publications:

5 Citations in Europe PMC

Data provided by Europe PubMed Central.

Forecasting and Analyzing the Disease Burden of Aged Population in China, Based on the 2010 Global Burden of Disease Study.
Bao C, Mayila M, Ye Z, Wang J, Jin M, He W, Chen K., Int J Environ Res Public Health 12(7), 2015
PMID: 26121188
Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J., BMJ 350(), 2015
PMID: 25985328
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany.
Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R., BMC Infect. Dis. 14(), 2014
PMID: 24993051
An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands.
McDonald SA, Presanis AM, De Angelis D, van der Hoek W, Hooiveld M, Donker G, Kretzschmar ME., Influenza Other Respir Viruses 8(1), 2014
PMID: 24209610
Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands.
McDonald SA, Mangen MJ, Suijkerbuijk A, Colzani E, Kretzschmar ME., BMC Infect. Dis. 13(), 2013
PMID: 23497182

37 References

Data provided by Europe PubMed Central.

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom.
Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H., Eur. J. Clin. Microbiol. Infect. Dis. 19(11), 2000
PMID: 11152308
Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.
Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, Larrauri A, Meijer A, Puzelli S, Rizzo C, Simonsen L; EPIA collaborators, Balderston C, Bella A, Perez-Brena P, Casas I, Cuadrado TL, de Mateo S, Donatelli I, Donker G, Edelman L, Elliot A, Fleming D, Glisman S, Heikkinen T, Larrauri A, de Lejarazu Leonardo RO, Mazick A, McMenamin J, Meijer A, Molbak K, Nielsen L, Paget J, Pnaiser R, Pregliasco F, Puzelli S, Reynolds A, Rizzo C, Simonsen L, Smith D, Sune TP, van der Sande M, Alonso TV, Vesikari T, Watson J, Weil-Olivier C, Zambon M, Ziegler T., Eur. J. Pediatr. 169(8), 2010
PMID: 20229049
Long time trends in influenza-like illness and associated determinants in The Netherlands.
Dijkstra F, Donker GA, Wilbrink B, Van Gageldonk-Lafeber AB, Van Der Sande MA., Epidemiol. Infect. 137(4), 2009
PMID: 18789176
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.
Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K., J. Infect. Dis. 178(1), 1998
PMID: 9652423
Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children.
Wijngaard CC, Asten Lv, Koopmans MP, Pelt Wv, Nagelkerke NJ, Wielders CC, Lier Av, Hoek Wv, Meijer A, Donker GA, Dijkstra F, Harmsen C, Sande MA, Kretzschmar M., PLoS ONE 7(2), 2012
PMID: 22319616

AUTHOR UNKNOWN, 2011
Projections of global mortality and burden of disease from 2002 to 2030.
Mathers CD, Loncar D., PLoS Med. 3(11), 2006
PMID: 17132052
[Effects of ageing on infectious disease].
Bijkerk P, van Lier EA, van Vliet JA, Kretzschmar ME., Ned Tijdschr Geneeskd 154(), 2010
PMID: 20977793
Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.
Hahne SJ, De Melker HE, Kretzschmar M, Mollema L, Van Der Klis FR, Van Der Sande MA, Boot HJ., Epidemiol. Infect. 140(8), 2012
PMID: 22078095
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK, Toy M, Hahne SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH., Gastroenterology 138(2), 2010
PMID: 19879275

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 23217094
PubMed | Europe PMC

Search this title in

Google Scholar